InvestorsObserver is giving Prestige Consumer Healthcare Inc (PBH) an Analyst Rating Rank of 28, meaning PBH is ranked higher by analysts than 28% of stocks. The average projection by analysts for PBH is $44 over the next 12 months and analyst’s classify the stock as a Buy
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
Investors Observer takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Prestige Consumer Healthcare Inc Stock Today?
Prestige Consumer Healthcare Inc (PBH) stock is down -0.84% while the S&P 500 is unmoved 0% as of 11:34 AM on Friday, Sep 25. PBH is lower by -$0.29 from the previous closing price of $34.54 on volume of 119,592 shares. Over the past year the S&P 500 is up 9.03% while PBH is lower by -1.44%. PBH earned $2.99 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 11.45.
Click Here to get the full report on Prestige Consumer Healthcare Inc (PBH) Stock.
